Nanotechnology based vaccines: Cervical cancer management and perspectives

Keyphrases

• Nanotechnology 100%
• Cervical Cancer Prevention 100%
• Therapeutic Vaccine 66%
• Immune Response 33%
• Cell-based 33%
• Cause of Death 33%
• Targeted Delivery 33%
• Clinical Trials 33%
• Cancer-related 33%
• Therapeutic Agents 33%
• High-risk Human Papillomavirus (HR-HPV) 33%
• Effective Management 33%
• Cervical Cancer 33%
• Human Papillomavirus Vaccine 33%
• Effective Prevention 33%
• Conventional Therapy 33%
• Suitable Target 33%
• Nucleic Acids 33%
• Vaccine Strategy 33%
• Protein-based 33%
• Neoplastic Disease 33%
• Peptide-based 33%
• Vaccine Antigen 33%
• Screening Strategy 33%
• Progressive Development 33%
• Early Vaccination 33%
• Effective Results 33%
• Vaccine Therapy 33%
• Premalignant Tissue 33%
• Live Vector Vaccines 33%
• Nanotechnological Approaches 33%
• Knowledge about Cervical Cancer 33%
• Early Genes 33%
• Gynecologic Malignancies 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Uterine Cervix Cancer 100%
• Malignant Neoplasm 60%
• Infection 60%
• Therapeutic Vaccine 40%
• Human Papillomavirus 20%
• Clinical Trial 20%
• Wart Virus Vaccine 20%
• Nucleic Acid 20%
• Neoplasm 20%
• Vaccination Policy 20%